A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorder

A prospective double-blind randomized control trial (RCT) to evaluate the benefit of a combinatorial, five gene pharmacogenomic test and interpretive report (GeneSight) for the management of psychotropic medications used in the treatment of major depression in an outpatient psychiatric practice. Dep...

Full description

Bibliographic Details

Published in:	Discovery medicine Vol. 16; no. 89; p. 219
Main Authors:	Winner, Joel G, Carhart, Joseph M, Altar, C Anthony, Allen, Josiah D, Dechairo, Bryan M
Format:	Journal Article
Language:	English
Published:	United States 01-11-2013
Subjects:	Adult Antidepressive Agents - therapeutic use Depressive Disorder, Major - drug therapy Depressive Disorder, Major - genetics Double-Blind Method Drug Administration Schedule Genotype Humans Treatment Outcome
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!